Canada markets close in 2 hours 16 minutes

Aridis Pharmaceuticals, Inc. (ARDS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.2650+0.0250 (+1.12%)
As of 01:23PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 35.93M
Enterprise Value 36.45M
Trailing P/E 2.83
Forward P/E 2.05
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.40
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.85

Trading Information

Stock Price History

Beta (5Y Monthly) 1.13
52-Week Change 3-46.28%
S&P500 52-Week Change 3-6.48%
52 Week High 34.3400
52 Week Low 30.8800
50-Day Moving Average 31.3410
200-Day Moving Average 31.8364

Share Statistics

Avg Vol (3 month) 3120.58k
Avg Vol (10 day) 3468.76k
Shares Outstanding 517.7M
Implied Shares Outstanding 6N/A
Float 813.44M
% Held by Insiders 118.12%
% Held by Institutions 111.66%
Shares Short (Jul 14, 2022) 496.73k
Short Ratio (Jul 14, 2022) 42.1
Short % of Float (Jul 14, 2022) 40.60%
Short % of Shares Outstanding (Jul 14, 2022) 40.55%
Shares Short (prior month Jun 14, 2022) 4187.67k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-1,588.39%

Management Effectiveness

Return on Assets (ttm)-130.59%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.72M
Revenue Per Share (ttm)0.19
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-35.4M
EBITDA -42.76M
Net Income Avi to Common (ttm)-46.21M
Diluted EPS (ttm)-3.2630
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.47M
Total Cash Per Share (mrq)0.7
Total Debt (mrq)12.99M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.64
Book Value Per Share (mrq)-1.15

Cash Flow Statement

Operating Cash Flow (ttm)-29.09M
Levered Free Cash Flow (ttm)-20.93M